SPI — Spire Healthcare Cashflow Statement
0.000.00%
- £740.27m
- £2.02bn
- £1.58bn
- 45
- 66
- 45
- 50
Annual cashflow statement for Spire Healthcare, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.9 | 3.9 | 34.6 | 38.3 | 18.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 77.2 | 94.9 | 92.9 | 92.3 | 109 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.4 | -15.1 | -15.6 | -7.1 | -5.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 184 | 182 | 216 | 236 | 242 |
| Capital Expenditures | -69.3 | -87.7 | -84.4 | -112 | -78.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 21 | -7.6 | -72.8 | 13.1 | -5.7 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -48.3 | -95.3 | -157 | -99 | -84.2 |
| Financing Cash Flow Items | -80 | -97.6 | -90.6 | -107 | -120 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -39.2 | -215 | -82.9 | -145 | -165 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 96.3 | -128 | -24.6 | -8.4 | -6.5 |